CN
Chanda Narang
About Chanda Narang
Data last updated:
Chanda Narang is a Director at Hennell Fine Collections Private Limited (since 2009) and Director at Hennell Medi Pharma Private Limited (since 2010). The companies operate in Consumer Goods and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹12.74 Cr; the largest is Hennell Fine Collections Private Limited at ₹12.70 Cr (FY 2024). Earlier, Chanda Narang was a Director at Royal Sterling (India) Private Limited (2002–2010).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hennell Fine Collections Private Limited U28900DL2009PTC188014 | Director | 27 Feb 2009 | 2009 | ₹12.70 Cr (FY 2024) | Active |
 Hennell Medi Pharma Private Limited U24232DL2010PTC201052 | Director | 01 Apr 2010 | 2010 | ₹3.6 Lakh (FY 2024) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Royal Sterling (India) Private Limited U74899DL1986PTC025872 | Director | 19 Sep 2002 | 1986 | ₹76.5 Lakh (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chanda Narang
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vijay Kumar Chawla | 02277690 | Hennell Fine Collections Private Limited | Director |
| Archana Kumari | 02556016 | Hennell Medi Pharma Private Limited | Director |
| Parmod Dutt | 09827773 | Hennell Medi Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chanda Narang
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chanda Narang
Chanda Narang currently holds 2 directorships: Hennell Fine Collections Private Limited (Director, since 27 Feb 2009, revenue ₹12.70 Cr (FY 2024)); Hennell Medi Pharma Private Limited (Director, since 01 Apr 2010, revenue ₹3.6 Lakh (FY 2024)).
Chanda Narang was first appointed on 19 Sep 2002 as Director at Royal Sterling (India) Private Limited. The most recent appointment on record is 01 Apr 2010 at Hennell Medi Pharma Private Limited.
The 2 current companies of Chanda Narang that report revenue have a combined latest revenue of ₹12.74 Cr: Hennell Fine Collections Private Limited ₹12.70 Cr (FY 2024); Hennell Medi Pharma Private Limited ₹3.6 Lakh (FY 2024).
Chanda Narang held 1 earlier board appointment: Royal Sterling (India) Private Limited (Director, 19 Sep 2002 to 12 Apr 2010).
The current boards of Chanda Narang's companies include Vijay Kumar Chawla (Hennell Fine Collections Private Limited), Archana Kumari (Hennell Medi Pharma Private Limited), Parmod Dutt (Hennell Medi Pharma Private Limited).